Epigentek Home

Product Categories

EpiQuik Total Histone Extraction Kit


Base Product #: OP-0006              Availability: Usually Ships In 1-2 Days
Share:
Displaying 1 to 1 (of 1 products) Result Pages:  1 
 Catalog No.+   Product Name   Select Qty.   Price 
 OP-0006-100  EpiQuik Total Histone Extraction Kit (100 extractions)   $102.00 
Product Overview

The EpiQuik™ Total Histone Extraction Kit provides a simple and selective method for extracting histone proteins used for a variety of applications, which include histone modification such as acetylation, methylation, and sumoylation. The kit can be used to extract histones from mammalian cells and tissues with the fastest procedure available on the current market, which can be finished within 60 minutes. The EpiQuik™ Total Histone Extraction Kits are also specifically designed to meet the requirements of histone extracts used in EpiQuik™ assays. Yield of the total histone proteins is approximately 0.4 mg per 107 cells or 100 mg of tissue. The yield may vary depending on cell or tissue type.

Product Details

The EpiQuik™ Total Histone Extraction Kit simply applies our proprietary histone isolation buffers to cells/tissues. After treatment with pre-lysis, lysis, and balance buffers, the total histones are easily extracted for immediate use or storage at proper conditions.

SCHEMATIC PROCEDURE:  



Histone extracts were prepared from MCF-7 cells using the EpiQuik Total Histone Extraction Kit and acetyl histone H3-K9 was quantified using the EpiQuik Global Acetylated Histone H3-K9 Quantification Kit (Fluorometric) (Cat. No. P-4011).
Product Components

10X Pre-Lysis Buffer
Lysis Buffer
Balance Buffer
DTT Solution
User Guide

Frequently Asked Q's

1. Will the buffer affect the histone modification status such as acetylation or methylation?
No, it will not.

2. What is the minimal amount of tissue that can be used for extraction?
1 mg, but for the best results, we recommend more than 10 mg.

User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

Product Citations

Itzhak, Y. et. al. (March 2012). Histone acetylation rescues contextual fear conditioning in nNOS KO mice and accelerates extinction of cued fear conditioning in wild type mice. Neurobiol Learn Mem. Epub ahead of print. PubMed Abstract

Wurm, T. et. al. (March 2012). The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP. Nucleic Acids Res. Epub ahead of print. PubMed Abstract

Neri, F. et. al. (February 2012). Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells. Mol Cell Biol. 32(4):840-51. PubMed Abstract

Ponomarev, I. et. al. (February 2012). Gene Coexpression Networks in Human Brain Identify Epigenetic Modifications in Alcohol Dependence. J. Neurosci. 32(5):1884-97. PubMed Abstract

Qu, F. et. al. (February 2012). A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl). Epub ahead of print. PubMed Abstract

Zhao, M. et. al. (February 2012). Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. Br J Dermatol. 166(2):226-73. PubMed Abstract

Yamamura, Y. et. al. (October 2011). TNF-a inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation. J Cell Mol Med. 141(8):1464-8. PubMed Abstract

Jing, L. et. al. (April 2011). Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. Neurosci Lett. 494(2): 169-73. PubMed Abstract 

Kawakami, K. et. al. (January 2011). Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Sci. 102(1): 166-74. PubMed Abstract

Hansen, A. et. al. (July 2010). Development of a drug screening platform based on engineered heart tissue. Circulation Research. 107(1): 35-44. PubMed Abstract

Diehl, F. et. al. (March 2010). Cardiac deletion of smyd2 is dispensable for mouse heart development. PLoS One. 5(3): e9748. PubMed Abstract

Feedback Form
Epigentek is an epigenetics company that specializes in epigenetic kits, antibodies, reagents, and services for epigenetic research in DNA methylation, histone modification, and chromatin studies.

Copyright © 2012 Epigentek Group Inc. All rights reserved.
Epigentek, the Epigentek logo, and the "Complete Solutions For Epigenetics" slogan are trademarks of Epigentek Group Inc.